Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial
Davide Pastorelli, Aline S.C. Fabricio, Petros Giovanis, et al.
Pharmacological Research (2018) Vol. 132, pp. 72-79
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Amit Choudhari, Pallavi Mandave, Manasi Deshpande, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 830
Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review
Mahshid Moballegh Nasery, Banafshe Abadi, Delaram Poormoghadam, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 689-689
Open Access | Times Cited: 243
Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer
Bee Ling Tan, Mohd Esa Norhaizan
Molecules (2019) Vol. 24, Iss. 14, pp. 2527-2527
Open Access | Times Cited: 214
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment
Paula García-Oliveira, Paz Otero, Antía G. Pereira, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 157-157
Open Access | Times Cited: 210
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial
Lynne Howells, Chinenye Iwuji, Glen R.B. Irving, et al.
Journal of Nutrition (2019) Vol. 149, Iss. 7, pp. 1133-1139
Open Access | Times Cited: 191
Improving Curcumin Bioavailability: Current Strategies and Future Perspectives
Rita Tabanelli, Simone Brogi, Vincenzo Calderone
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1715-1715
Open Access | Times Cited: 184
Advances in phytochemical delivery systems for improved anticancer activity
Ricardo Lagoa, João Silva, Joaquim Rui Rodrigues, et al.
Biotechnology Advances (2019) Vol. 38, pp. 107382-107382
Closed Access | Times Cited: 180
Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature
Mahmood Barani, Enrico Sangiovanni, M. Angarano, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 6983-7022
Open Access | Times Cited: 178
Is curcumin bioavailability a problem in humans: lessons from clinical trials
Ajaikumar B. Kunnumakkara, Choudhary Harsha, Kishore Banik, et al.
Expert Opinion on Drug Metabolism & Toxicology (2019) Vol. 15, Iss. 9, pp. 705-733
Closed Access | Times Cited: 174
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
Quan Gao, Jiao Feng, Wen‐Cheng Liu, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114445-114445
Closed Access | Times Cited: 163
Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs
Man Wang, Shuai Jiang, Li Zhou, et al.
International Journal of Biological Sciences (2019) Vol. 15, Iss. 6, pp. 1200-1214
Open Access | Times Cited: 156
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 189-213
Closed Access | Times Cited: 151
Impacts of turmeric and its principal bioactive curcumin on human health: Pharmaceutical, medicinal, and food applications: A comprehensive review
Mohamed T. El‐Saadony, Tao Yang, Sameh A. Korma, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 143
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
Mangala Hegde, Sosmitha Girisa, Bandari BharathwajChetty, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 10713-10746
Open Access | Times Cited: 111
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials
Ajaikumar B. Kunnumakkara, Mangala Hegde, Parama Dey, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 447-518
Open Access | Times Cited: 92
Effects and Mechanisms of Curcumin for the Prevention and Management of Cancers: An Updated Review
Zhijun Yang, Siyu Huang, Dan-Dan Zhou, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1481-1481
Open Access | Times Cited: 84
Role of natural products in tumor therapy from basic research and clinical perspectives
Zhisen Wang, Zhengcheng Liu, Jiao Qu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 19
Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics
Srimanta Patra, Biswajita Pradhan, Rabindra Nayak, et al.
Seminars in Cancer Biology (2020) Vol. 73, pp. 310-320
Closed Access | Times Cited: 116
Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
Milad Ashrafizadeh, Ali Zarrabi, Farid Hashemi, et al.
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1084-1084
Open Access | Times Cited: 105
Targeting Bcl-2 for cancer therapy
Linlin Zhang, Zaiming Lu, Xiangxuan Zhao
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188569-188569
Closed Access | Times Cited: 87
Molecular Targets of Natural Compounds with Anti-Cancer Properties
Małgorzata Kubczak, Aleksandra Szustka, Małgorzata Rogalińska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13659-13659
Open Access | Times Cited: 77
Curcumin nanoformulations to combat aging-related diseases
Maryam Mahjoob, Ursula Stochaj
Ageing Research Reviews (2021) Vol. 69, pp. 101364-101364
Closed Access | Times Cited: 69
Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies
Ana María Castañeda, Carlos Mario Meléndez, Diego Uribe, et al.
Heliyon (2022) Vol. 8, Iss. 6, pp. e09519-e09519
Open Access | Times Cited: 64
The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer
Naoshad Muhammad, Darksha Usmani, Mohammad Tarique, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2209-2209
Open Access | Times Cited: 64
Curcumin Supplementation (Meriva®) Modulates Inflammation, Lipid Peroxidation and Gut Microbiota Composition in Chronic Kidney Disease
Francesca Pivari, Alessandra Mingione, Giada Piazzini, et al.
Nutrients (2022) Vol. 14, Iss. 1, pp. 231-231
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top